Kintara Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaborations
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Events
    • Recent News
  • Investors
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers

Publications and Abstracts

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Events
  • Recent News
American Association of Cancer Research (AACR) Annual Meeting

American Association of Cancer Research (AACR) Annual Meeting

Phase I/II Study of Dianhydrogalactitol in Patients with Recurrent Malignant Glioblastoma

Apr 19, 2016
American Association of Cancer Research (AACR) Annual Meeting

American Association of Cancer Research (AACR) Annual Meeting

Enhanced in vitro activity of dianhydrogalactitol (VAL-083) in combination with platinum drugs: impact of p53 and platinum-resistance

Apr 18, 2016
Society for Neuro-Oncology Poster

Society for Neuro-Oncology Poster

Phase I/II Study of Dianhydrogalactitol in Patients with Recurrent Malignant Glioma

Nov 20, 2015
AACR New Horizons in Cancer Research Conference: Bringing Cancer Discoveries to Patients

AACR New Horizons in Cancer Research Conference: Bringing Cancer Discoveries to Patients

The unique mechanism of action of dianhydrogalactitol (VAL-083) may provide a new treatment option for chemo-resistant cancers

Nov 13, 2015
AACR Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship

AACR Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship

Dianhydrogalactitol (VAL-083) Offers Potential Therapeutic Alternatives in the Treatment of Pediatric Brain

Nov 10, 2015
2015 Canadian Cancer Research Conference

2015 Canadian Cancer Research Conference

Exploring the Molecular Mechanisms of Dianhydrogalactitol (VAL-083) in Cancer Treatment

Nov 9, 2015
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Dianhydrogalactitol (VAL-083) enhances activity of platinum drugs in non-small cell lung cancer

Nov 6, 2015
American Association for Cancer Research (AACR) Advances in Ovarian Cancer Research: Exploiting Vulnerabilities Conference

American Association for Cancer Research (AACR) Advances in Ovarian Cancer Research: Exploiting Vulnerabilities Conference

A comparison of mechanisms and cytotoxic activity of dianhydrogalactitol (VAL-083) to cisplatin in ovarian tumor models harbouring wild-type and mutant p53

Oct 19, 2015

16th World Conference on Lung Cancer, Denver, Colorado

Tuesday, September 8, 2015 poster session. Post-Market Clinical Trial of Dianhydrogalactitol in the Treatment of Relapsed or Refractory Non-Small Cell Lung Cancer

Sep 8, 2015

GBM2015: 2nd International Symposium on Clinical and Basic Investigation in Glioblastoma in Toledo, Spain

Tuesday, September 8, 2015 poster session. Update on Phase 1/2 study of VAL-083 (dianhydrogalactitol) in patients with recurrent malignant glioma

Sep 8, 2015
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next »
© 2022 Kintara Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences